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A B S T R A C T   
Introduction: Musculoskeletal pain (MSP) is a burden to patients and to society. In addition to well-known 
prognostic factors, illness perceptions (IPs) may be associated with pain intensity and physical functioning in 
MSP but their role is not fully understood. Our research focused on these questions: 1) Do IPs differ between 
patients with acute, sub-acute and persistent MSP 2) Are IPs, in addition to well-known prognostic factors, 
associated with pain intensity and with limitations in physical functioning? 
Methods: Eligible MSP patients from 29 physical therapy practices were invited to participate in a cross-sectional 
study. IPs were measured with the Brief IPQ-DLV. We compared IPs between patients with acute, sub-acute and 
persistent MSP (1-way ANOVA with Tukey post-hoc tests). Secondly, associations between IPs with pain intensity 
and physical functioning were assessed (multiple linear regression). 
Results: With 658 participants, most IP dimensions showed small differences between acute, sub-acute or 
persistent pain. For pain intensity, the IP dimensions Consequences, Identity and Comprehensibility explained an 
additional 13.3% of the variance. For physical functioning, the dimensions Consequences, Treatment Control, 
Identity and Concern explained an additional 26.5% of the variance. 
Discussion/conclusion: Most IP dimensions showed small differences between acute, sub-acute or persistent pain. 
In addition to some well-known prognostic variables, higher scores on some IP dimensions are associated with 
higher pain intensity and more limitations in physical functioning in patients with MSP. Longitudinal studies are 
needed to explore the longitudinal associations.   
1. Introduction 
Musculoskeletal pain (MSP) is recognized worldwide as a main cause 
of increased years lived with disability. This illustrates clearly that 
Musculoskeletal pain (MSP) is a burden on patients as MSP is a major 
cause of pain and limitations in physical functioning (Vos et al., 2013). 
These limitations include problems in the mobility of patients but also 
limitations in the ability to work and problems in actively participating 
in all aspects of life (March et al., 2014). In addition, MSP is also a 
burden to society. Direct health care costs, social compensation, retire-
ment pensions, and other indirect costs contribute to this load (Woolf 
et al., 2012). 
Understanding the associations between various patient and disease 
characteristics in MSP is one important challenge in order to be able to 
improve the management for MSP and to reduce the burden of MSP, 
both to patients and society. 
Patients’ beliefs about their pain, is one of these patient character-
istics that may be associated with the intensity of pain and limitations in 
physical functioning in MSP (de Raaij et al., 2018). Across 15 
cross-sectional studies on 9 different musculo-skeletal conditions, the 
researchers found limited to moderate evidence for a consistent direc-
tion of the relationship of illness perceptions with pain intensity and 
physical function. Higher maladaptive illness perceptions imply stron-
ger pain intensity and more limitation in physical function. 
A framework which explores patients’ beliefs about their MSP is the 
Common Sense Model of Self-Regulation of health and illness (Leventhal 
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et al., 2016). This CSM is based on a parallel processing model, 
describing individual representations in response to health threats. 
These representations are called Illness Perceptions (IPs). Based on 
initial clinical research, five IP dimensions were identified (Box 1). 
Ongoing research explored this in more depth and added the dimensions 
of Timeline Cyclical (periodical changes in symptoms), Comprehensi-
bility (making sense of the illness), Emotional Representations (impact 
on emotional level) and Concern (anxiousness about the illness) to the 
CSM (Moss-Morris et al., 2002; Broadbent et al., 2006). 
In most MSP cases (i.e. low back pain), a specific cause for the pain 
cannot be identified and consequently MSP is frequently labelled as non- 
specific (Hartvigsen, 2018; Carlson and Carlson, 2011). Non-specific 
MSP can be classified according to the duration of pain as acute (<7 
weeks), subacute (7–13 weeks) or persistent (>13 weeks) (Dionne et al., 
2008). It is not known whether IPs differ between acute and chronic 
patients with MSP. Therefore, our first research question was: Do illness 
perceptions differ between patients with acute, subacute and persistent 
musculoskeletal pain? 
A second important topic is to identify prognostic factors for MSP 
outcomes and there are a few well-known prognostic factors in relation 
to the ongoing patient burden of MSP: pain intensity, limitations in 
physical functioning, multiplicity of pain-sites, pain duration and the 
psychological factors somatization, distress, anxiety and depression 
(Pincus et al., 2002), (Hartvigsen, 2018), (OSullivan et al., 2016), (Artus 
et al., 2017), (Nahit et al., 2003). However, little is known about the 
additional role IPs might play in pain intensity and limitations in 
physical functioning, up and above the prognostic value of these 
well-known prognostic factors. Especially in outpatients with MSP 
attending physical therapy practices this is unknown. In this multicentre 
explorative cross-sectional study, we hypothesized that higher scores on 
IPs, in addition to these well-known factors, would be associated with 
higher pain intensity and limitations in physical functioning in MSP. 
Therefore, our second research question was: What is the additional as-
sociation of illness perceptions with pain intensity or limitations in physical 
functioning in addition to the independent factors pain sites, pain duration, 
and the psychological factors somatization, distress, anxiety, and depression 
in patients with musculoskeletal pain, adjusted for gender and age? 
2. Materials and methods 
2.1. Design and setting 
This multicentre cross-sectional study took place at 29 primary care 
physiotherapy clinics across The Netherlands. Physiotherapists at these 
centres collected the data as part of their Master of Physiotherapy study 
at University of Applied Sciences Utrecht, The Netherlands Participants 
were asked to complete several questionnaires prior to their first 
consultation. Demographic characteristics and clinical variables 
collected in daily practice included age, gender, pain intensity (PI), and 
the completed Patient-Specific Functional Scale (PSFS) for limitations in 
physical functioning. The known prognostic factors of persistent pain 
were measured with questions about the number of pain sites, pain 
duration, and the Four-Dimensional Symptom Questionnaire (4DSQ). 
Finally, illness perceptions (participants’ beliefs about their MSP) were 
measured using the Brief Illness Perception Questionnaire Dutch Lan-
guage Version (Brief IPQ-DLV). 
2.2. Study population 
Over a period of three months, all consecutive patients, if eligible, 
were asked to participate in the study. Included were patients with MSP, 
aged between 18 and 75 years. Exclusion criteria were the presence of 
red flags, specific musculoskeletal diseases or physiotherapy treatment 
within six months prior to the first consultation. The study was approved 
by the Medical Ethical Committee of the …………………….., ………… 
(ref. no. 430002016) and all participating patients signed an informed 
consent form. 
2.3. Measurements overview 
In this study, pain intensity (PI) and the Patient-Specific Functional 
Scale (PSFS) for limitations in physical functioning were the primary 
outcomes. IPs were the observed exposure variables of primary interest. 
Based on published research, multiple pain sites, pain duration, and the 
psychological factors somatization, distress, anxiety, and depression 
were considered to be important prognostic factors for the persistence of 
MSP (Pincus et al., 2002), (Hartvigsen, 2018), (OSullivan et al., 2016), 
(Artus et al., 2017), (Nahit et al., 2003) and were therefore included in 
this study. 
2.4. Pain intensity 
To measure the average PI in the last 24 h, we used the Numeric 
Rating Scale (NRS). This is an 11-point rating scale in which 0 is no pain 
and 10 the worst pain imaginable (Ferreira-Valente et al., 2011). 
2.5. Patient-Specific Functional Scale 
Physical functioning was assessed with the PSFS, which is known to 
be a feasible and reliable instrument (Stevens et al., 2017; Beurskens 
et al., 1999). 
2.6. Multiple pain sites 
Participants were asked to register the number of different sites in 
which they experienced pain. We categorized the outcomes into 2 
groups; 1) 1 pain site, 2) � 2 pain sites. 
2.7. Pain duration 
Participants were asked how long their pain had existed prior to 
consultation. We categorized the outcomes into 3 groups; 1) acute pain 
<7 weeks, 2) subacute pain 7–13 weeks, 3) persistent pain >13 weeks. 
2.8. Psychological measures 
The Four-Dimensional Symptom Questionnaire (4DSQ) was used to 
assess participants’ levels of risk for distress, depression, anxiety, and 
Box 1 
Illness perception dimensions.  
1) Identity; the label or name given to the condition by patients and the symptoms that are perceived to go with it.  
2) Timeline Chronic; how long the patient believes the illness will last.  
3) Consequences; how strong the impact is of patients’ illness on e.g. pain or physical functioning.  
4) Causal beliefs; patient’s beliefs about what causes the illness.  
5) Control beliefs; patients beliefs about how to control or recover from the illness.  
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somatization: it is reported to show good reliability (18). Sum scores 
were calculated and cutoff points (Terluin et al., 2016) applied to 
categorize each participant as being at low, medium or high risk (Box 2). 
2.9. Illness perceptions 
The Brief IPQ-DLV was used as it has acceptable psychometric 
properties (de Raaij et al., 2012; Hallegraeff et al., 2013). This ques-
tionnaire consists of nine questions: eight questions are scored on a 0–10 
scale; the ninth question is an open-ended question about the dimension 
‘Cause’. 
2.10. Statistics 
Descriptive statistics of demographic variables were reported as 
mean and standard deviation. Missing value analysis was performed and 
<5% missing data was assumed to be inconsequential (Schafer, 1999). 
For sample size in stepwise regression, several rules of thumbs are re-
ported in literature. Ranging from 50 participants þ8 - 30 per inde-
pendent variable. We used a rule of thumb for a minimum sample size of 
50 þ >30 per independent variable based on the recommendations 
when expecting small associations (Wilson Van Voorhis and Morgan, 
2007). The one-way ANOVA with Tukey post-hoc test was used to 
examine the differences between the three pain duration groups. 
To examine the additional association of illness perceptions with 
pain intensity or limitation in physical functioning, a multiple linear 
regression was used. First, age, gender and the well-known prognostic 
factors were entered as ‘fixed’ in the model. Second, with univariate 
association we detected the most promising IPs (defined as those with 
p < 0.10) and added these to the model. We checked on multicollinearity 
between the IPs, and the distribution of residuals. A variable was 
considered redundant if its VIF value (indication of multicollinearity) 
was above 5. Our final model will report if IPs significantly add to the 
explained variance of pain and physical function, after adjusting for age, 
gender and well-known prognostic factors. 
3. Results 
A total of 658 patients were included in this study: their demographic 
characteristics are reported in Table 1. For the IPs in the univariate as-
sociation (Table 3) missing value analyses showed that no IPs variable 
exceeded over 3.8 percent assumed to be inconsequential. 
3.1. Differences in illness perceptions and pain duration 
Illness perceptions mean scores and standard deviations are reported 
in Table 2. The total between-groups difference was statistically signif-
icant, apart from the IP dimension Comprehensibility. The mean dif-
ferences between acute pain and subacute pain were significant for two 
out of eight IP dimensions, namely Timeline and Concern. The mean 
differences between acute pain and persistent pain were significant for 
seven out of eight IP dimensions (not Comprehensibility). For subacute 
pain and persistent pain, the differences were significant for two out of 
eight IP dimensions, namely Timeline and Identity. Overall, absolute 
point differences were small, with the largest between-groups points 
differences, ranging between 1 and 3, being for the IP dimensions 
Timeline, Concern and Emotional. 
3.2. Association of IPs with pain intensity and physical functioning 
In Table 3, Univariate associations of IPs with pain intensity and 
physical functioning are reported. The IP dimensions that were signifi-
cantly correlated (p � 0.10) with pain and physical function were added 
into the multiple linear regressions. The strength of the significant IP 
dimensions association with pain intensity varies; Identity r ¼ 0.41, 
Consequences r ¼ 0.36, Concern and Emotional r ¼ 0.28, Timeline 
r ¼ 0.18, Comprehensibility r ¼ 0.10. Also, the IP dimensions associa-
tion with physical function varies: Consequences r ¼ 0.48, Identity 
r ¼ 0.47, Emotional r ¼ 0.32, Concern r ¼ 0.26, Timeline r ¼ 0.23, 
Treatment control r ¼   0.16. 
3.3. Multiple regression: pain intensity/physical functioning and illness 
perceptions 
For the independent variable pain intensity, the IP dimensions Per-
sonal Control and Treatment Control were not univariately significantly 
correlated and were therefore not added to the model. Also, for physical 
functioning, the IP dimension Personal Control was not added to the 
model. No multicollinearity was found between the IPs, and residuals 
were found to be distributed normally. 
3.4. Pain intensity 
The multiple linear regression (Table 4) showed 22.9% of explained 
variance. The IP dimensions Consequences (beta ¼ 0.098), Identity 
(beta ¼ 0.273) and Comprehensibility (beta ¼ 0.084) were the 
statistically-significant contributors to pain intensity. 
Box 2 
Cut off points 4DSQ.   
Distress Depression Anxiety Somatization 
Low risk 0 – 10 0 – 2 0 – 3 0 – 10 
Medium risk 11 – 20 3 – 5 4 – 9 11 – 20 
High risk 21 – 32 6 – 12 10 – 24 21 – 32   
Table 1 
Demographic characteristics of participating patients N ¼ 658.   
Pain duration groups in weeks prior to consultation 
<7 n ¼ 226 7–13 n ¼ 116 >13 n ¼ 316 
Age years, mean 
(sd) 
44.5 (13.7) 48.8 (13.0) 46.9 (14.6) 
Female (%) 134 (63.3) 79 (68.1) 224 (71.0) 
Pain duration in 
weeks mean (sd) 
3.2 (1.5) 9.7 (1.8) 181.0 (336.6) 
Pain 
intensity < 24 h 
0–10 mean (sd) 
5.2 (2.2) 5.0 (2.2) 5.2 (2.4) 
Physical 
functioning 
0–10 mean (sd) 
6.2 (2.4) 5.9 (2.2) 6.3 (2.2) 
�2 pain sites (%)  25 (11.1) 23 (19.8) 115 (36.4) 
Direct access (%) 130 (57.6) 56 (48.7) 118 (37.3) 
sd ¼ standard deviation. 
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In the first step (where the confounders and prognostic factors were 
entered into the model), the explained variance was 9.6%. This means 
that an additional 13.3% of the variance was explained by adding the IPs 
to the model. 
3.5. Physical functioning 
The multiple linear regression (Table 4) showed 32.2% of explained 
variance. The IP dimensions Consequences (beta ¼ 0.283), Identity 
(beta ¼   0.113), Treatment Control (beta ¼ 0.240) and Concern 
(beta ¼   0.108) were the statistically-significant contributors to phys-
ical functioning. In the first step (where the confounders and prognostic 
factors were entered into the model), the explained variance was 5.7%. 
This means that an additional 26.5% of the variance was explained by 
adding the IPs to the model. 
4. Discussion 
To our knowledge, this is the first multicentre study of IPs in patients 
with MSP in primary care physiotherapy. Our findings enhance the 
understanding of IPs as possible associating factors with pain intensity 
and limitations in physical functioning in MSP. 
4.1. Illness perceptions and pain duration 
Our results show most IPs being significantly different between the 
pain-duration groups of acute, subacute and persistent pain. However, 
looking at the absolute mean differences between pain-duration groups, 
most IPs show no relevant difference apart from the IP Timeline. This 
invites the hypothesis that, the longer a patient experiences MSP, the 
higher the score on the IP Timeline will be. None of the other IP di-
mensions exceeded the smallest detectable change of 2.5 (de Raaij et al., 
2012). Therefore, the differences according to pain duration in most IPs 
are not clinically relevant. This might indicate that high scoring (mal-
adaptive) IPs are equally important for patients with acute, sub-acute 
and persistent pain. This is supported by qualitative research about 
perceptions, such as vulnerability, and poor prognoses for back pain 
(Darlow et al., 2015). In this study, patients shared the same beliefs 
Table 2 
Comparisons of mean scores on the illness perception dimensions between three pain duration groups   
Mean (sd) per group  Tukey post hoc test 
1 2 3 Overall Group 1-2 Group 2-3 Group 1-3 
< 7 weeks 7 – 12 weeks � 13 weeks  p p d p d p d 
Consequences 4.4 (2.8) 4.9 (2.7) 5.6 (3.0) p < 0.005 0.43 - 0.04 0.51 - 0.08 p < 0.005 - 0.12 
Timeline 3.3 (2.7) 4.7 (2.9) 6.2 (3.4) p < 0.005 p < 0.005 - 0.06 p < 0.005 - 0.07 0.00 - 0.07 
Personal Control 4.9 (2.5) 5.1 (2.5) 5.2 (2.6) 0.04 0.78 - 0.04 0.38 - 0.08 0.03 - 0.12 
Treatment Control 2.5 (1.9) 2.9 (1.9) 3.2 (2.3) p < 0.005 0.13 - 0.08 0.57 - 0.04 p < 0.005 - 0.12 
Identity 5.3 (2.4) 5.3 (2.3) 6.1 (2.4) p < 0.005 0.98 0.01 p < 0.005 - 0.11 p < 0.005 - 0.11 
Concern 3.1 (2.8) 4.0 (2.8) 4.8 (3.0) p < 0.005 0.01 - 0.07 0.05 - 0.05 p < 0.005 - 0.13 
Comprehensibility 3.1 (2.4) 3.6 (2.5) 3.3 (2.5) 0.10 0.18 - 0.16 0.66 0.09 0.42 - 0.06 
Emotional 3.8 (2.9) 4.3 (3.0) 4.9 (3.0) p < 0.005 0.31 - 0.06 0.20 - 0.07 p < 0.005 - 0.13 
sd ¼ standard deviation, p ¼ statistical significant, d ¼ Cohen’s d effect size. 
Table 3 
Univariate associations (r) between the illness perceptions and pain intensity or physical functioning.   
Pain Intensity 
N ¼ 648 
Physical Functioning 
N ¼ 630 
N r p N r p 
IP dimension 
Consequences 635 0.36 p < 0.005 618 0.48 p < 0.005 
Timeline 624 0.18 p < 0.005 606 0.23 p < 0.005 
Personal Control 633 0.06 0.131 616 0.02 0.590 
Treatment Control 626   0.04 0.319 612   0.16 p < 0.005 
Identity 633 0.41 p < 0.005 616 0.47 p < 0.005 
Concern 630 0.28 p < 0.005 613 0.26 p < 0.005 
Comprehensibility 623 0.10 0.011 606   0.10 (0.011) 
Emotional 633 0.28 p < 0.005 614 0.32 p < 0.005 
N ¼ sample size, IP ¼ Illness Perception. 
Table 4 
Final model multiple linear regression of illness perceptions on pain intensity and physical functioning.  
Illness perception dimensions R2 Changeda R2 effect 95% CI SE p 
Pain intensity N ¼ 607 22.9% 13.3%     
Consequences   0.098 (0.005, 0.192) 0.127 0.04 
Identity   0.273 (0.167, 0.378) 0.285 <0.005 
Comprehensibility   0.084 (0.016, 0.152) 0.092 0.02 
Physical functioning N ¼ 588 32.2% 26.5%     
Consequences   0.283 (0.194, 0.372) 0.368 <0.005 
Treatment Control   - 0.113 (-0.194,   0.033) - 0.107 0.01 
Identity   0.240 (0.139, 0.340) 0.255 <0.005 
Concern   - 0.108 (-0.185,   0.030) - 0.143 0.01  
a 
¼ changed explained variance after adding illness perceptions to the model effects adjusted for Age, Gender, � 2 pain sites, pain duration, risk of: Distress, 
Depression, Somatization, and Anxiety only significant illness perceptions are reported. 
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about their pain condition despite having acute or persistent pain. 
Though caution in the interpretation of the results is required, due to 
recall bias (Grimes and Schulz, 2002) and the cross-sectional design, we 
see possible implications for the management of MSP. 
First, if maladaptive IPs contribute to the burden of MSP, screening 
for these in patients with acute or sub-acute MSP might be advised and 
could be done by using validated questionnaires (Moss-Morris et al., 
2002)((Broadbent et al., 2006; de Raaij et al., 2012). Second, consid-
ering IPs could be a supplementary procedure to the use of risk strati-
fication tools, such as the Keele STarT MSK Tool or STarT Back 
Screenings Tool (Hill et al., 2008), (Bier et al., 2017) for predicting poor 
recovery from MSP. In this way, the assessment of IPs might contribute 
to the identification of possible relevant psychosocial risk factors for 
poor recovery from MSP. 
4.2. Illness perceptions and pain intensity 
The IP dimensions Consequences, Identity and Comprehensibility 
explained an additional 13.3% to the initially-explained variance for 
pain intensity. As this is a rather substantial increase, this might imply 
that these IPs could potentially be relevant for the management of these 
patients. For instance, if a patient with MSP shows maladaptive IPs, such 
as ‘My condition has a high impact on my daily life’ or ‘I don’t understand 
where my pain comes from’, these IPs could be risk factors for poor re-
covery and therefore should be assessed. Also, identifying maladaptive 
IPs opens opportunities for treatment options in trying to change these 
perceptions. To our knowledge, no studies have to date researched as-
sociations of IPs with pain intensity, or the changing of maladaptive IPs, 
within primary physiotherapy care (de Raaij et al., 2018). Consequently, 
we recommend further research to explore the possibilities of identi-
fying IPs as risk factors and to study the feasibility of changing mal-
adaptive IPs. 
4.3. Illness perceptions and limitations in physical functioning 
For physical functioning, the additional explained variance of the IP 
dimensions Consequences, Timeline, Personal Control, Identity and 
Emotional Representations was 26.5%. This could mean that these IPs 
are potentially important for clinical practice. This is in line with the 
results from a RCT for persistent low back pain. A total of 10–14 h of 
cognitive treatment of IPs by occupational therapists resulted in 
statistically-significant and clinically-relevant improvements in patient- 
relevant physical activities at 18 weeks (Siemonsma et al., 2013). 
Included were patients with persistent LBP of, on average, more than 
one year’s duration. We know of no intervention studies targeting high 
IP scores within a population having less than one year’s MSP. We 
recommend further exploration of the feasibility of changing IPs by 
physiotherapists for improving patients’ physical functioning, not only 
for persistent LBP but also for acute and sub-acute LBP. 
4.4. Limitations and strengths 
First, the cross-sectional design prevents a causal interpretation of 
the findings. The main aim of this study, however, was to explore 
whether IPs and, if so, which IPs were associated with pain intensity and 
physical functioning. Secondly, despite the large and geographically 
wide-ranging sample in the Netherlands, selection bias may exist since 
there is no information available regarding patients that did not sign an 
informed consent form and were therefore not included in this study. 
Thirdly, bias on the outcomes of pain duration cannot be excluded since 
these rely on the recall of the patients, which has been found to be un-
reliable. Patients with persistent MSP have to search further back in 
their memory than those with acute MSP, thereby producing less reliable 
data (Grimes and Schulz, 2002). Fourthly, the well-known prognostic 
factors did not contribute to the model. This may be explained by the 
fact that we chose well-known prognostic factors from studies on 
chronicity of MSP. We did not find studies on prognostic factors for pain 
intensity in MSP so we hypothesized that prognostic factors for chro-
nicity might also be factors that mediate in the association of IPs with 
pain intensity and physical functioning. Our findings suggest that most 
prognostic factors for chronicity of MSP do not mediate the association 
between IPs, pain intensity and physical functioning. 
A major strength of our study is its multicentered basis in the primary 
care setting throughout the Netherlands. This means that the MSP 
population in this research can be compared with patients attending any 
general physiotherapist in the Netherlands, and results can be general-
ized to the Dutch MSP patients visiting physiotherapists. Secondly, for 
prognostic studies, Hayden et al. proposed a three-phase framework: 
“Phase 1, identifying associations; Phase 2, testing independent associ-
ations; and Phase 3, understanding prognostic pathways” (Hayden et al., 
2008). We have performed the first Phase 2 study exploring the 
cross-sectional independent association of IPs with pain intensity and 
physical functioning in primary physiotherapy care. We recommend 
further exploration of these pathways in a Phase 3 explanatory study, 
where IPs are explored longitudinally for their predictive value for pain 
intensity and physical functioning. 
4.5. Practical implications 
Maladaptive beliefs about MSP may contribute to pain intensity and 
limitations in physical functioning. Higher IP scores on Consequences, 
Identity and Comprehensibility were associated with higher pain in-
tensity. Higher IP scores on Consequences, Treatment Control, Identity 
and Concern were associated with greater limitations in physical func-
tioning. Due to the cross-sectional design of our study, a causal inter-
pretation is not possible in patients with MSP, but this has already been 
shown in cohorts of patients with persistent pain from repetitive strain 
injury (Sluiter and Frings-Dresen, 2007) and low back pain (Bishop 
et al., 2015). This highlights the therapeutic potential of targeting higher 
IP scores and trying to alter maladaptive IPs to more favourable, adap-
tive, ones. Changing IPs is not only relevant for alleviating the burden of 
MSP, but also for reducing dependence on physiotherapy treatment. 
Higher scores on IPs are associated with more frequent use of physio-
therapy (Opseth et al., 2017). Finally, our study calls for a Phase 3 
explanatory study in which the IPs are explored longitudinally for their 
predictive value on pain intensity and physical functioning. 
5. Conclusion 
Most IP dimensions showed small differences between acute, sub- 
acute or persistent pain. In addition to some well-known prognostic 
factors, some higher scores in IP dimensions are associated with higher 
pain intensity and more limitations in physical functioning in patients 
with MSP. Longitudinal studies are needed to indicate the direction of 
the association. 
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